Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 45,298

Document Document Title
WO/2014/030726
The invention pertains to a protein production accelerator that makes it possible to add polysaccharides to an animal cell culture medium containing serum or serum replacement and greatly increase the amount of the desired protein produc...  
WO/2014/030165
The present invention provides transgenic microalgae expressing at least one exogenous biologically active protein. The protein-expressing microalgae are used for the oral delivery of the biologically active protein to the target organis...  
WO/2014/030597
A compound represented by general formula (I); a method for producing the compound; a microorganism capable of producing the compound; a pharmaceutical composition containing the compound; an anti-tumor agent comprising the pharmaceutica...  
WO/2014/029862
This disclosure provides to a new tall fescue grass endophyte (Neotyphodium coenophialum) referred to as 647, as well as to synthetic combinations of the 647 endophyte and tall fescue grass plant or tall fescue grass cultivar. This new e...  
WO/2014/030841
With respect to Hydrodictyon sp. algae of which a mass production method has not been reported, among freshwater algae, the present invention provides an economical and efficient method for the massive culturing, high quality biomass, cu...  
WO/2014/030745
Provided is a method for producing ethanol with high efficiency through the ethanol fermentation from xylose using a saccharified biomass that contains various fermentation-inhibiting substances. A method for producing ethanol from a bio...  
WO/2014/030655
The purpose of the present invention is to provide: a transformant which can produce lactic acid with high productivity without requiring the neutralization with an alkaline agent; a method for producing the transformant; and a method fo...  
WO/2014/028521
Disclosed herein is a Bacillus strain, Bacillus sp. isolate F727, that produces metabolites with pesticidal activities. Also provided are bioactive compositions and metabolites derived from cultures of Bacillus sp. isolate F727 capable o...  
WO/2014/026770
A method of introducing a target gene sequence into a primed algal cell, comprising a step of providing a primed algal cell comprising providing an algal cell; introducing into the algal cell an integration cassette comprising at least t...  
WO/2014/028258
Disclosed herein are non-vascular photosynthetic organisms that have been modified by either knockdown or knockout of a gene. Methods of making the modified non-vascular photosynthetic organisms are also described herein. The modified no...  
WO/2014/027864
The present invention provides a novel lactic acid bacterium having antioxidant and antiaging functions and a dementia alleviation effect, and more specifically, provides Lactobacillus pentosus var. plantarum C29 KCCM11291P and Lactobaci...  
WO/2014/027821
The present invention relates to a weed control composition comprising novel Streptomyces scopuliridis KR-001 strains or a culture medium thereof as an active ingredient. More particularly, the Streptomyces scopuliridis KR-001 strains, t...  
WO/2014/027129
A microorganism of the species Pseudomonas putida has been isolated and identified and has been found to be a super-producer which is naturally capable of: a) metabolizing various sources of carbon, including aromatic derivatives, b) gro...  
WO/2014/027702
The present invention describes a method for producing L-amino acid such as L-arginine by fermentation using a bacterium of the family Enterobacteriaceae, particularly a bacterium belonging to the genus Escherichia, which has been modifi...  
WO/2014/028520
Provided are bioactive compositions and metabolites derived from Bacillus and particularly Bacillus megaterium cultures responsible for controlling pests as well as their methods of use for controlling pests. Further provided are pestici...  
WO/2014/026310
Provided are an ion channel protein NHX1-1 from cotton and coding genes thereof, and the use in the incubation of transgenic plants with increased salt tolerance.  
WO/2014/028848
The present disclosure relates to compositions and methods for targeted killing of microorganisms. In particular, the present disclosure relates to the use of Lysobacter gummosus and compositions containing Lysobacter gummosus in targete...  
WO/2014/028026
Provided herein are methods for the production of difunctional alkanes in microorganisms. Also provided are enzymes and nucleic acids encoding such enzymes, associated with the difunctional alkane production from carbohydrates feedstocks...  
WO/2014/027863
The present invention relates to a microalgae cultivation device using mine drainage and, more particularly, to a microalgae cultivation device including an incubator and having a removable pipe.  
WO/2014/027871
The present invention is related to the systems and methods of disruption of biomass of renewable resources - algal cells - by applying the rotating induced magnetic field, and isolation of bioproducts accumulated in the algal cells, suc...  
WO/2014/026136
The present invention generally relates to bacterial polypeptide display systems, libraries using these bacterial display systems, and methods of making and using these systems, including methods for improved display of polypeptides on t...  
WO/2014/024998
Provided is a method for selectively culturing a microorganism in a simple manner and at low cost, which enables the selective culture of a microorganism of interest without employing any sterilizing procedure or without using any antibi...  
WO/2014/025514
A method of making a flowable, agglomerated nutrient medium is provided. The method comprises forming a nutrient medium composition by placing a powdered nutrient into a fluidized bed-type agglomeration chamber, flowing a fluidizing gas ...  
WO/2014/023129
Provided are a new α-conotoxin peptide, and a medical composition and a purpose thereof. Further provided are a propeptide, a nucleic acid construct, an expression vector, a transformed cell and a fusion protein of the conotoxin peptide...  
WO/2014/024013
The present invention relates to novel compounds of formula (I) and pharmaceutically acceptable salts thereof, a process for the preparation thereof, as well as pharmaceutical compositions containing them and the use thereof as drugs, pa...  
WO/2014/026162
This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modi...  
WO/2014/023917
The invention relates to a method for preparing a composition rich in lutein produced by microalgae, particularly microalgae belonging to the Chlorella genus, more specifically produced by Chlorella vulgaris, characterized in that said m...  
WO/2014/024914
Provided is a peptide library. A peptide selected from items (1) and (2). A peptide selected from items (i) and (ii): (i) a peptide which contains the amino acid sequence represented by SEQ ID NO: 1 shown in the Sequence Listing and also...  
WO/2014/025941
The present disclosure relates to the use of a switch for the production of heterologous non-catabolic compounds in microbial host cells. In one aspect, provided herein are genetically modified microorganisms that produce non-catabolic c...  
WO/2014/024013
The present invention relates to novel compounds of formula (I) and pharmaceutically acceptable salts thereof, a process for the preparation thereof, as well as pharmaceutical compositions containing them and the use thereof as drugs, pa...  
WO/2014/025604
The present application relates to recombinant microorganisms comprising engineered biosynthetic pathways and methods of using said recombinant microorganisms to produce various beneficial metabolites. In various aspects of the invention...  
WO/2014/023992
The application relates to a Yersinia pseudotuberculosis cell, which comprises nucleic acid coding for expression of at least one Yersinia pestis Caf1 polypeptide or of at least one antigenic fragment of Yersinia pestis Caf1, more partic...  
WO/2014/025605
The present compositions and methods relate to variant Ascomycetes sp. fungal cells that are genetically-modified to reduce the production of peptaibols, especially when grown on substrates containing insoluble material.  
WO/2014/025020
Provided is a culture method for microalgae that cultures microalgae in a liquid containing at least a fermented liquor. Provided is a method for using microalgae that makes it possible to efficiently utilize organic compounds stored in ...  
WO/2014/020290
The present invention concerns strains of Sarcocystidae chosen from Toxoplasma spp or Neospora spp isolated from the natural environment of same and having an immunostimulating effect for the use of same in the prevention or treatment, i...  
WO/2014/020933
Provided is a fluorescent substance which is highly safe when administered to a living body and is derived from a nucleic acid. A material for testing for fluorescence is used, which comprises at least one biological substance selected f...  
WO/2014/021533
The present invention relates to a microorganism having an acetyl CoA biosynthesis pathway and a butyryl CoA biosynthesis pathway; the microorganism being a recombinant microorganism having an increased ability to produce butanol, wherei...  
WO/2014/021339
It is found that a monoclonal antibody capable of recognizing at least two amino acid residues among amino acid residues located at position-69, position-79, position-81 and position-102 in human midkine has excellent reactivity with hum...  
WO/2014/019634
The invention relates to a device (1) and a method for treating a porous filtration medium (37) having a receiving unit (2) consisting of a receiving part (5) and a base part (6), wherein the porous filtration medium (37) can be received...  
WO/2014/019271
Biomarkers for diabetes and usages thereof are provided. And the biomarkers are Akkermansia muciniphilacBacteroides intestinaliscBacteroides sp. 20_3cClostridium bolteaec Clostridium hathewayicClostridium ramosumcClostridium sp. HGF2cClo...  
WO/2014/020291
The present invention concerns a mutant strain of Neospora spp, in which the function of the protein NcMIC3 and/or the function of the protein NcMIC1 is suppressed, and the uses thereof in a pharmaceutical composition or in a vaccine com...  
WO/2014/020215
The invention relates to a method for large-scale production of mycelial inoculum of ascomycota. Large-scale production of ascomycota is of great commercial interest, in particular that of important species belonging to the Tuber, Terfez...  
WO/2014/020653
[Problem] To provide: a method for breeding a novel species by interspecies crossing among Pleurotus sp. varieties such as Pleurotus eryngii (DC. :Fr.) Quel, Pleurotus eryngii (DC. :Fr.) Quel. var. elaeoselini, Pleurotus eryngii (DC. :Fr...  
WO/2014/021508
The present invention relates to a high strain containing high lipid content. The novel strain of the present invention contains high lipid content, high fatty acid content, and in particular contains palmitic acid, and therefore, can be...  
WO/2014/022692
In some aspects, the invention provides methods of modulating yeast fermentation or growth by modulating the [GAR+] prion. In some embodiments, [GAR+] is induced by contacting yeast cells with a bacterium that produces a small molecule i...  
WO/2014/021205
The present invention addresses the problem of providing: a lactic acid bacterium which has at least one effect selected from a fatigue-improving effect, a blood flow-improving effect, a stool odor-improving effect and a growth-promoting...  
WO/2014/021733
The invention relates to the field of microbiology and biotechnology, particularly to lactobacillus strains which can be used in food and medical biotechnology. Proposed are the strains Lactobacillus crispatus 2029 (ВКМ B-2727D), Lact...  
WO/2014/020520
The present invention relates to an algal fiber material comprising at least one metal ion selected from the group consisting of copper, iron, manganese, potassium, silver, nickel, zinc, cadmium and combinations thereof, wherein said alg...  
WO/2014/019696
The present invention concerns a semi-solid transport medium for isolation and identification of Helicobacter pylori, which comprises, for one litre of medium: 6.5 to 7.2 g granulated agar, 9.5 to 10.5 g enzymatic digest of casein, 9 to ...  
WO/2014/018596
The invention provides compositions and methods for engineering E. coli or other host production bacterial strains to produce fucosylated oligosaccharides, and the use thereof in the prevention or treatment of infection.  

Matches 351 - 400 out of 45,298